March 2, 2026 — Esaote Group will officially launch the new MyLab E85 and MyLab C30 GTS Edition ultrasound systems at the European Congress of Radiology 2026 in Vienna (March 4-8).

“With these new ultrasound systems, our goal is to give interventional radiologists the most reliable and intuitive tools to support every phase of their procedures,” says Marta Daniel, GTS Product and Clinical Solutions Manager at Esaote.  

Feb. 26, 2026 — AS Software, a provider of specialty-focused ultrasound reporting solutions, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Asera, the next-generation version of its ultrasound reporting platform.

Asera represents an evolution of AS Software, maintaining the same intended use and core clinical functionality while introducing a redesigned user experience, enhanced workflows, and a scalable, cloud-based architecture.

Feb. 26, 2026 — GE HealthCare and UCSF Health have announced a 10-year Care Alliance collaboration focused on implementing advanced imaging and strengthening care delivery across the health system. UCSF Health will implement GE HealthCare imaging solutions across multiple clinical settings, furthering UCSF's leadership in clinical translation efforts to directly impact patient care.

March 2, 2026 — Emory Healthcare researchers, led by Dr. Eric R. Wagner, recently published a study comparing two well-established treatment options for cuff-intact glenohumeral osteoarthritis in the shoulder. Using Konica Minolta's Dynamic Digital Radiography (DDR), the team evaluated which surgical technique most effectively restores native shoulder biomechanics.

Feb. 26, 2026 — DeepHealth, Inc., a provider of AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc., recently announced TechLive, its FDA-cleared remote imaging and radiology management solution, has achieved CE marking, enabling European commercialization of the industry’s first solution that extends oversight across MR, CT, PET/CT and ultrasound.

Feb. 26, 2026  — GT Medical Technologies, a company focused on improving the lives of patients with brain tumors, has announced the publication of prospective, multicenter Phase IV data from the ongoing GammaTile Registry — which has enrolled more than 600 patients to date — evaluating clinical outcomes following surgical resection with immediate, localized GammaTile radiation therapy in patients with newly diagnosed brain metastases.

Feb. 27, 2026 — A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research published in The Journal of Nuclear Medicine.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now